Thromb Haemost 1975; 34(02): 455-464
DOI: 10.1055/s-0038-1651404
Original Article
Schattauer GmbH

Studies on PIVKA-X

Gustav Gaudernack
1   Institute of Medical Biology, University of Tromsø, Tromsø, Norway
,
Hans Prydz
1   Institute of Medical Biology, University of Tromsø, Tromsø, Norway
› Author Affiliations
Further Information

Publication History

Received 13 December 1974

Accepted 19 May 1975

Publication Date:
02 July 2018 (online)

Preview

Summary

The incorporation of 14C-glucosamine and 3H-leucine into PIVKA-X and factor X has been studied in Macaca mulatta by means of a monospecific precipitating antiserum. No difference in the incorporation into PIVKA-X and factor X was found.

The half-lives of PIVKA-X and factor X were similar (about 30-35 h and 27-31 h respectively) indicating that the vitamin K-induced modifications did not alter the survival of protein.

A Russell’s-viper venom/cephalin test system for factor X was more sensitive to inhibition by PIVKA-X than was a tissue thromboplastin-based system.